Congenital Myasthenic Syndrome

Rare Disease·MeSH: Myasthenic Syndromes, Congenital

Prevalence

0.5 / 100K

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Congenital Myasthenic Syndrome?

There are 2 clinical trials targeting Congenital Myasthenic Syndrome tracked by BioSniper.

What is the prevalence of Congenital Myasthenic Syndrome?

The estimated prevalence of Congenital Myasthenic Syndrome is approximately 0.5 per 100,000 population.

Deep-dive into Congenital Myasthenic Syndrome

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Congenital Myasthenic Syndrome — Drugs in Development & Clinical Trials | BioSniper